Cost-of-illness analysis of patients with chronic hand eczema in routine care in germany: Focus on the impact of occupational disease

Acta Dermato-Venereologica

Volumn 93, Issue 5, 2013, Pages 538-543

  Diepgen, Thomas L ^a   Purwins, Sandra ^b   Posthumus, Jan ^c   Kuessner, Daniel ^c   John, Swen M ^d   Augustin, Matthias ^d  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c BASILEA PHARMACEUTICA INTERNATIONAL LTD   (Switzerland)

^d UNIVERSITY OF OSNABRÜCK   (Germany)

Author keywords

Chronic hand eczema; Costs; Health insurance; Occupational contact dermatitis; Refractory; Sick leave; Work status

Indexed keywords

CALCINEURIN INHIBITOR; EMOLLIENT AGENT; STEROID;

ADULT; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; COST OF ILLNESS; DRUG COST; FEMALE; GERMANY; HAND ECZEMA; HEALTH CARE COST; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL ECZEMA; PRIORITY JOURNAL; TOPICAL TREATMENT;

ABSENTEEISM; ADULT; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; FEMALE; GERMANY; HAND DERMATOSES; HEALTH CARE COSTS; HEALTH CARE SURVEYS; HEALTH EXPENDITURES; HUMANS; INCOME; LOGISTIC MODELS; MALE; MIDDLE AGED; MODELS, ECONOMIC; OCCUPATIONAL DISEASES; OCCUPATIONAL HEALTH; ODDS RATIO; PROGNOSIS; SEVERITY OF ILLNESS INDEX; SICK LEAVE; TIME FACTORS;

EID: 84883469457     PISSN: 00015555     EISSN: 16512057     Source Type: Journal    
DOI: 10.2340/00015555-1565     Document Type: Article

References (19)

1. Meding B, Swanbeck G. Consequences of having hand eczema. Contact Dermatitis 1990; 23: 6-14.
2. Diepgen TL, Agner T, Aberer W, Berth-Jones J, Cambazard F, Elsner P, et al. Management of chronic hand eczema. Contact Dermatitis 2007; 57: 203-210.
3. Bissonnette R, Diepgen TL, Elsner P, English J, Graham-Brown RA, Homey B, et al. Redefning treatment options in chronic hand eczema (CHE). J Eur Acad Dermatol Venereol 2010; 24: 1-20.
4. Lynde C, Guenther L, Diepgen TL, Sasseville D, Poulin Y, Gulliver W, et al. Canadian hand dermatitis management guidelines. J Cutan Med Surg 2010; 14: 267-284.
5. Apfelbacher CJ, Akst W, Molin S, Schmitt J, Bauer A, Weisshaar E, et al. CARPE: a registry project of the German Dermatological Society (DDG) for the characterization and care of chronic hand eczema. J Dtsch Dermatol Ges 2011; 9: 682-688.
6. Augustin M, Kuessner D, Purwins S, Hieke K, Posthumus J, Diepgen TL. Cost-of-illness of patients with chronic hand eczema in routine care: results from a multicentre study in Germany. Br J Dermatol 2011; 165: 845-851.
7. Cortesi PA, Scalone L, De Pità O, Angelini G, Cristaudo A, Girolomoni G, et al. Prevalence and cost of severe chronic hand eczema refractory to topical potent corticosteroids.Value in Health 2011; 14: A490.
8. Malkonen T, Alanko K, Jolanki R, Luukkonen R, Aalto-Korte K, Lauerma A, et al. Long-term follow-up study of occupational hand eczema. Br J Dermatol 2010; 163: 999-1006.
9. Thyssen JP, Johansen JD, Linneberg A, Menne T. The epidemiology of hand eczema in the general population - prevalence and main fndings. Contact Dermatitis 2010; 62: 75-87.
10. Diepgen TL, Andersen KE, Brandao FM, Bruze M, Bruyn-zeel D P, Frosch P, et al. Hand eczema classifcation: a cross-sectional, multicentre study of the aetiology and morphology of hand eczema. Br J Dermatol 2009; 160: 353-358.
11. Ruzicka T, Lynde CW, Jemec GB, Diepgen T, Berth-Jones J, Coenraads PJ, et al. Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial. Br J Dermatol 2008; 158: 808-817.
12. Coenraads PJ, Van Der Walle H, Thestrup-Pedersen K, Ruzicka T, Dreno B, De La Loge C, et al. Construction and validation of a photographic guide for assessing severity of chronic hand dermatitis. Br J Dermatol 2005; 152: 296-301.
13. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216.
14. Augustin M, Wenninger K, Amon U, Schroth MJ, Kuster W, Chren M, et al. German adaptation of the Skindex-29 questionnaire on quality of life in dermatology: validation and clinical results. Dermatology 2004; 209: 14-20.
15. Chren MM, Lasek RJ, Quinn LM, Mostow EN, Zyzanski SJ. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol 1996; 107: 707-713.
16. Diepgen TL, Elsner P, Schliemann S, Fartasch M, Kollner A, Skudlik C, et al. Guideline on the management of hand eczema ICD-10 Code: L20. L23. L24. L25. L30. J Dtsch Dermatol Ges 2009; 7: S1-16.
17. Diepgen TL. Occupational skin diseases. J Dtsch Dermatol Ges 2012; 10: 297-313.
18. Diepgen T, Scheidt R, Weisshaar E, John SM, Hieke K. Cost of illness of occupational hand eczema in Germany. Contact Dermatitis (in press).
19. Hongbo Y, Thomas CL, Harrison MA, Salek MS, Finlay AY. Translating the science of quality of life into practice: what do dermatology life quality index scores mean? J Invest Dermatol 2005; 125: 659-664.